Skip to main content
Equibles

DIADEMA PARTNERS LP

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 2026172 MORRISTOWN, NJ
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$60,093 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Derivatives in VTGN

reported options exposure · as of Jun 30, 2026
CallValue
$13,271
CallShares
57,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 139,218 $26,072,747
2 ABVX
Abivax S.A.
 163,644 $21,807,199
3 COGT
Cogent Biosciences, Inc.
 493,664 $19,104,796
4 BMRN
Biomarin Pharmaceutical Inc
 312,846 $17,901,048
5 VKTX
Viking Therapeutics, Inc.
 441,808 $17,234,930
6 EWTX
Edgewise Therapeutics, Inc.
 272,214 $11,060,054
7 KOD
Kodiak Sciences Inc.
 218,117 $8,497,838
8 IMCR
Immunocore Holdings plc
 254,863 $8,091,900

All Filings in VTGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,271 57,700
2026-03-31 $60,093 105,428
2025-12-31 $66,000 100,000
2025-12-31 $70,290 106,500
2025-09-30 $1,241,750 349,789
2025-09-30 $355,710 100,200
2025-06-30 $400 200
2025-06-30 $807,844 403,922
2025-03-31 $500 200
2025-03-31 $1,414,937 565,975
2024-12-31 $1,305,434 442,520
2024-12-31 $590 200